Optiver Holding’s Ginkgo Bioworks DNA Stock Holding History

Optiver Holding’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-127	Closed	-$779	–	2848
2026 Q1	$779	Hold	127	–	–	﹤0.01%	2101
2025 Q4	$1.05K	Hold	127	–	–	﹤0.01%	2213
2025 Q3	$1.85K	Hold	127	–	–	﹤0.01%	2407
2025 Q2	$1.43K	Hold	127	–	–	﹤0.01%	1368
2025 Q1	$724	Hold	127	–	–	﹤0.01%	1293
2024 Q4	$1.25K	Hold	127	–	–	﹤0.01%	971
2024 Q3	$1.03K	Sell	127 -500	-80%	-$5.01K	﹤0.01%	901
2024 Q2	$8.39K	Buy	+627	New	+$18.7K	﹤0.01%	738

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Optiver Holding's DNA Position: Q2 2026 in Review

Optiver Holding sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 127 shares — an estimated $779 sold.

Optiver Holding first reported a position in DNA in Q2 2024 and held it in 8 quarters. The position peaked at $8.39K in Q2 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Optiver Holding reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 127 Ginkgo Bioworks shares in Q2 2026, an estimated $779.
Optiver Holding first reported a position in Ginkgo Bioworks in Q2 2024 and held it in 8 quarters.
Optiver Holding's Ginkgo Bioworks position peaked at $8.39K in Q2 2024.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.